SPOCK2 Modulates Neuropathic Pain by Interacting with MT1-MMP to Regulate Astrocytic MMP-2 Activation in Rats with Chronic Constriction Injury
Overview
Affiliations
Background: Neuropathic pain (NP) is a kind of intractable pain. The pathogenesis of NP remains a complicated issue for pain management practitioners. SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2 (SPOCK2) are members of the SPOCK family that play a significant role in the development of the central nervous system. In this study, we investigated the role of SPOCK2 in the development of NP in a rat model of chronic constriction injury (CCI).
Methods: Sprague-Dawley rats were randomly grouped to establish CCI models. We examined the effects of SPOCK2 on pain hpersensitivity and spinal astrocyte activation after CCI-induced NP. Paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) were used to reflects the pain behavioral degree. Molecular mechanisms involved in SPOCK2-mediated NP in vivo were examined by western blot analysis, immunofluorescence, immunohistochemistry, and co-immunoprecipitation. In addition, we examined the SPOCK2-mediated potential protein-protein interaction (PPI) in vitro coimmunoprecipitation (Co-IP) experiments.
Results: We founded the expression level of SPOCK2 in rat spinal cord was markedly increased after CCI-induced NP, while SPOCK2 downregulation could partially relieve pain caused by CCI. Our research showed that SPOCK2 expressed significantly increase in spinal astrocytes when CCI-induced NP. In addition, SPOCK2 could act as an upstream signaling molecule to regulate the activation of matrix metalloproteinase-2 (MMP-2), thus affecting astrocytic ERK1/2 activation and interleukin (IL)-1β production in the development of NP. Moreover, in vitro coimmunoprecipitation (Co-IP) experiments showed that SPOCK2 could interact with membrane-type 1 matrix metalloproteinase (MT1-MMP/MMP14) to regulate MMP-2 activation by the SPARC extracellular (SPARC_EC) domain.
Conclusions: Research shows that SPOCK2 can interact with MT1-MMP to regulate MMP-2 activation, thus affecting astrocytic ERK1/2 activation and IL-1β production to achieve positive promotion of NP.
Spinal astrocytes involved in the pathogenesis and treatment of neuropathic pain.
Li X, Huang Y, Bai J Front Cell Neurosci. 2025; 19:1547524.
PMID: 40062207 PMC: 11885516. DOI: 10.3389/fncel.2025.1547524.
Chen Y, Li T Int J Mol Sci. 2025; 26(4).
PMID: 40004233 PMC: 11855056. DOI: 10.3390/ijms26041770.
SPOCK2 controls the proliferation and function of immature pancreatic β-cells through MMP2.
Blaszczyk K, Jedrzejak A, Ziojla N, Shcheglova E, Szarafin K, Jankowski A Exp Mol Med. 2024; 57(1):131-150.
PMID: 39741186 PMC: 11799530. DOI: 10.1038/s12276-024-01380-2.
Zhu J, Zhou C, Huang L, Guo J, Yin N, Yang F Sci Rep. 2024; 14(1):31388.
PMID: 39732918 PMC: 11682254. DOI: 10.1038/s41598-024-82913-7.
Liu Y, Cai X, Shi B, Mo Y, Zhang J, Luo W Mol Neurobiol. 2024; 62(4):4654-4676.
PMID: 39470872 DOI: 10.1007/s12035-024-04562-1.